A Phase 1/2 study of exploring the safety tolerablility and efficacy of Epacadostat in combination with Durvalumab in subjects with selected advanced solid tumors.

Administered By

Awarded By

Contributors

Start/End

  • October 1, 2016 - June 9, 2020